Ellex Medical Lasers Limited announced the resignation of Mr. Malcolm Plunkett as a Director of the Company. Throughout his four and a half year tenure as a Director, Mr. Plunkett has been a full time executive in the business responsible for research and development and has made a significant contribution to the business. He will continue in this executive role concentrating on bringing the 2RT project through to market release and managing the business's research portfolio.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 AUD | 0.00% |
|
-2.22% | -8.33% |
Mar. 15 | Nova Eye Medical Completes Retail Entitlement Offer | MT |
Feb. 22 | Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.33% | 33.58M | |
+4.98% | 217B | |
+7.44% | 191B | |
+28.22% | 154B | |
+33.19% | 112B | |
+1.22% | 62.75B | |
+16.51% | 53.34B | |
+1.45% | 48.88B | |
-4.53% | 39.36B | |
+2.74% | 35.73B |
- Stock Market
- Equities
- EYE Stock
- News Nova Eye Medical Limited
- Ellex Medical Lasers Limited Announces the Resignation of Malcolm Plunkett as A Director